DENVER, Jan. 03, 2019 (GLOBE NEWSWIRE) — BioScrip, Inc. (NASDAQ: BIOS) (“BioScrip” or the “Company”), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf, President and Chief Executive Officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Thursday, January 10, 2019 at 8:00 a.m. Pacific Time in San Francisco, CA.
A live audio webcast of the presentation and copies of materials presented can be accessed via the Company’s Investor Relations website at https://investors.bioscrip.com/. A replay of the presentation also will be available following the conclusion of the live event.
About BioScrip, Inc.
BioScrip, Inc. is the largest independent national provider of infusion and home care management solutions, with approximately 2,100 teammates and nearly 70 service locations across the U.S. BioScrip partners with physicians, hospital systems, payors, pharmaceutical manufacturers and skilled nursing facilities to provide patients access to post-acute care services. BioScrip operates with a commitment to bring customer-focused pharmacy and related healthcare infusion therapy services into the home or alternate-site setting. By collaborating with the full spectrum of healthcare professionals and the patient, BioScrip provides cost-effective care that is driven by clinical excellence, customer service, and values that promote positive outcomes and an enhanced quality of life for those it serves.
Investor Contacts:
Stephen Deitsch Kalle Ahl, CFA
Chief Financial Officer & Treasurer The Equity Group
T: (720) 697-5200 T: (212) 836-9614
stephen.deitsch@bioscrip.com kahl@equityny.com